ArticleJournal of sleep research2026
Serum Concentrations of Cytokines in Patients With Restless Legs Syndrome.
Article in Journal of sleep research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum Biomarkers in Restless Legs Syndrome: Beyond the Classical Iron Paradigm-A Scoping Review.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Several data suggested a possible role of inflammatory factors in restless legs syndrome (RLS). In this regard, the results of a limited number of studies assessing serum or plasma levels of cytokines have been inconclusive. To investigate the possible role of several cytokines (tumour necrosis factor α-TNF-α, and interleukins-IL-1α, IL-1β, IL-6 and IL-10) as markers of idiopathic RLS (iRLS), we have measured their serum levels in a large series of iRLS patients and controls. We assessed serum levels of TNF-α, IL-1α, IL-1β, IL-6 and IL-10 in 100 patients diagnosed with iRLS and 110 age- and sex-matched healthy controls using a monoclonal Enzyme-Linked ImmunoSorbent Assay (ELISA) method. Serum levels of IL-1α and IL-1β were below detection limits both in iRLS patients and controls. Serum TNF-α, IL-6 and IL-10 levels did not differ significantly between iRLS patients and controls in the whole series, although TNF-α levels were lower in male iRLS patients compared with male iRLS controls. Serum TNF-α, IL-6 and IL-10 levels were not correlated with age at onset and severity of RLS. The data from the current study suggest that serum levels of the cytokines studied cannot be considered useful markers of iRLS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.